Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Crinetics Pharmaceuticals, Inc. | Director | Common Stock | 9.4K | $446K | $47.49 | Jun 7, 2024 | Direct |
Crinetics Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 12.5K | Jun 7, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CRNX | Crinetics Pharmaceuticals, Inc. | Jun 7, 2024 | 2 | $0 | 4 | Jun 11, 2024 | Director |
CRNX | Crinetics Pharmaceuticals, Inc. | Jun 16, 2023 | 2 | $0 | 4 | Jun 21, 2023 | Director |
CRNX | Crinetics Pharmaceuticals, Inc. | Jun 17, 2022 | 1 | $0 | 4 | Jun 21, 2022 | Director |
CRNX | Crinetics Pharmaceuticals, Inc. | Jun 22, 2021 | 1 | $0 | 4 | Jun 23, 2021 | Director |